Journal of Translational Medicine · 2013 · 24 citations · 25 references
MedicineMolecular BiologyMolecular MedicineEarly DetectionGene ExpressionMolecular DiagnosticsBiomarker DiscoveryCancer BiomarkersMicrorna BiologyMolecular BiomarkersMolecular ScreeningRna-based DiagnosticsCell-free Rna AnalysisCirculating Microrna DetectionCirculating MicrornasCirculating Rna BiomarkersMessenger Rna Biomarker AnalysisMicrorna BiomarkersMicrorna Expression ProfilingMicrorna Screening
BACKGROUND: Early disease detection with a minimally invasive screening test will significantly increase effectiveness and decrease the cost of treatment. Here we propose a framework of a novel approach - Universal Screening Test (UST) for the detection of pathological processes in a particular organ system, organ, or tissue by RT-qPCR analysis of circulating cell-free miRNAs in plasma. As the first step towards assessing the feasibility of this concept, the present study was designed to analyze whether the same microRNAs (miRNAs) can detect various diseases of a particular organ system. METHODS: RNA was extracted from plasma using Trizol treatment and silica binding. Levels of miRNAs were measured by single target RT-qPCR. The following innovations have been tested and proven effective: (i) the use of organ system/organ/tissue-enriched miRNAs; (ii) the use of miRNAs associated with broad disease categories, such as cancer and inflammation, in combination with the organ-enriched miRNAs; and (iii) the use of "miRNA pairs" for selecting miRNA combinations with the highest sensitivity and specificity. RESULTS: Here we report biomarker miRNA pairs effectively differentiating (i) patients with pulmonary system diseases (asthma, pneumonia and non-small cell lung cancer) and gastrointestinal (GI) system diseases (Crohn's disease, stages I/II esophageal, gastric and colon cancers) from controls, each with 95% accuracy; (ii) patients with a pathology of the pulmonary system from patients with a pathology of the GI system with 94% accuracy; and (iii) cancer patients (stages I/II esophageal, gastric, colon cancers, or non-small cell lung cancer) from patients with inflammatory diseases (asthma, pneumonia, or Crohn's disease) with 93%-95% accuracy. CONCLUSIONS: The results obtained in the present study, along with the data reported by us and others previously, are encouraging and lay the ground for further investigation of the described approach for UST development.
25
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Pablo Landgraf, Mirabela Rusu, Robert P. Sheridan et al. · Cell · 2007 · 3.7K citations · Full text
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Melissa Piper Hunter, Noura Ismail, Xiaoli Zhang et al. · PLoS ONE · 2008 · 1.4K citations · Full text
Characterization of microRNA expression profiles in normal human tissues
Yu Liang, Dana Ridzon, Linda Wong et al. · BMC Genomics · 2007 · 1K citations · Full text
Detection and Characterization of Placental MicroRNAs in Maternal Plasma
S Chim, Tristan K F Shing, Emily C W Hung et al. · Clinical Chemistry · 2008 · 863 citations